54 phenotypes from 2 alleles in 6 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Anxa1em1(IMPC)Ccpcz/Anxa1em1(IMPC)Ccpcz C57BL/6NCrl-Anxa1em1(IMPC)Ccpcz/Ccpcz	abnormal auditory brainstem response	J:211773
	abnormal epididymis morphology	J:211773
	abnormal heart morphology	J:211773
	abnormal spleen morphology	J:211773
	abnormal thymus morphology	J:211773
	abnormal uterus morphology	J:211773
	decreased circulating iron level	J:211773
	enlarged epididymis	J:211773
	enlarged heart	J:211773
	enlarged spleen	J:211773
	enlarged thymus	J:211773
	enlarged uterus	J:211773
	increased airway resistance	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating aspartate transaminase level	J:211773
	small kidney	J:211773
	small spleen	J:211773
Anxa1tm1Rjf/Anxa1+ Not Specified	increased inflammatory response	J:81498
Anxa1tm1Rjf/Anxa1tm1Rjf involves: 129 * C57BL	abnormal adrenal gland secretion	J:129587
	abnormal corticotroph morphology	J:135972
	abnormal folliculo-stellate cell morphology	J:135972
	abnormal gonadotroph morphology	J:135972
	abnormal lactotroph morphology	J:135972
	abnormal somatotroph morphology	J:135972
	decreased corticotroph cell size	J:135972
	normal homeostasis/metabolism phenotype	J:129587, J:135972
	increased adrenocorticotropin level	J:135972
	thin adrenal cortex	J:129587
Anxa1tm1Rjf/Anxa1tm1Rjf involves: 129 * C57BL/6	abnormal tumor vascularization	J:153690
	abnormal vascular endothelial cell migration	J:153690
	abnormal vascular endothelial cell physiology	J:153690
	decreased metastatic potential	J:153690
	decreased susceptibility to induced morbidity/mortality	J:153690
	decreased tumor growth/size	J:153690
	decreased vascular endothelial cell proliferation	J:153690
	delayed wound healing	J:153690
Anxa1tm1Rjf/Anxa1tm1Rjf involves: BALB/c	abnormal colon morphology	J:142735
	abnormal intestinal epithelium morphology	J:142735
	increased susceptibility to induced colitis	J:142735
	increased susceptibility to xenobiotic induced morbidity/mortality	J:142735
	weight loss	J:142735
Anxa1tm1Rjf/Anxa1tm1Rjf involves: C57BL/6	abnormal cranium morphology	J:129618
	abnormal frontal bone morphology	J:129618
	abnormal neurocranium morphology	J:129618
	abnormal palatine bone morphology	J:129618
	abnormal sagittal suture morphology	J:129618
	ectopic cranial bone	J:129618
	increased bone mineral density	J:129618
Anxa1tm1Rjf/Anxa1tm1Rjf Not Specified	abnormal adipose tissue morphology	J:115806
	abnormal adipose tissue physiology	J:115806
	abnormal fat pad morphology	J:115806
	abnormal leukocyte physiology	J:81498
	delayed wound healing	J:194294
	impaired macrophage phagocytosis	J:81498
	increased circulating insulin level	J:115806
	increased inflammatory response	J:81498